Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17259169 | 1.00 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL17209435 | 1.00 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL30341835 | 1.00 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL17660855 | 0.96 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL19180894 | 0.96 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL19180811 | 0.91 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL19180810 | 0.91 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL19179620 | 0.90 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL17661482 | 0.90 | IRAK4 (1.00) | IRAK4 | |
| SCHEMBL19179621 | 0.90 | IRAK4 (1.00) | IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4132524-A1 | ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS | Aclaris Therapeutics, Inc. (US) | 2023-02-15 | — | — | EP | disclosed |